Stephen Bane
Otolaryngology/Facial Plastic Surgery · Woodbridge, VANPI 1528046349
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Optinose US, Inc. at 42.1% of the total. 2025 is the largest year on record at $700, 4.5 times the $155 reported in 2019.
Across 115 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$939
- Sanofi$278
- Regeneron Healthcare Solutions, Inc.$199
- Stryker$148
- GSK$141
- Acclarent, Inc$97
- plus $426 from 15 others
What the payments were for
- Food & beverage$2,17397%
- Education$563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 68 | $939 |
| Sanofi | 9 | $278 |
| Regeneron Healthcare Solutions, Inc. | 7 | $199 |
| Stryker | 3 | $148 |
| GSK | 7 | $141 |
| Acclarent, Inc | 1 | $97 |
| Aerin Medical Inc. | 2 | $57 |
| Alk-abello, Inc | 3 | $48 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $47 |
| Galderma Laboratories, L.p. | 2 | $44 |
| Intersect ENT, Inc. | 1 | $30 |
| AstraZeneca | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $27 |
| Novo Nordisk | 1 | $23 |
| Novartis | 1 | $21 |
| Neurent Medical Limited | 1 | $20 |
| Medtronic | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Resmed Corp | 1 | $16 |
| Olympus America Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few otolaryngology/facial plastic surgery providers in Virginiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinolone Acetonide Oil | 11 | $328 |
| Cephalexin | 51 | $216 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 40 | $103 |
| Prednisone | 51 | $103 |
| Diazepam | 46 | $68 |
| Ondansetron OdtOndansetron | 31 | $57 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Woodbridge
- Michael ArmstrongRichmond$11K
- Michael AbidinAlexandria$5K
- Christopher TsangFairfax$4K
- Matthew HubbardAbingdon$3K
- Brian DeutschNorfolk$2K
- Nariman DashFredericksburg$2K
- Nima VahidiRichmond$2K
- John LieserFredericksburg$1K
- Alan BurkeRichmond$1K
- Jacob KuperstockFairfax$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.